Login / Signup

Enhancement of Vaccine-Induced T-Cell Responses by PD-L1 Blockade in Calves.

Tomohiro OkagawaSatoru KonnaiHayato NakamuraOtgontuya GanbaatarYamato SajikiKei WatariHaruka NodaMitsuru HonmaYukinari KatoYasuhiko SuzukiNaoya MaekawaShiro MurataKazuhiko Ohashi
Published in: Vaccines (2023)
Interactions between programmed death 1 (PD-1) and PD-ligand 1 (PD-L1) cause functional exhaustion of T cells by inducing inhibitory signals, thereby attenuating effector functions of T cells. We have developed an anti-bovine PD-L1 blocking antibody (Ab) and have demonstrated that blockade of the interaction between PD-1 and PD-L1 reactivates T-cell responses in cattle. In the present study, we examined the potential utility of PD-1/PD-L1-targeted immunotherapy in enhancing T-cell responses to vaccination. Calves were inoculated with a hexavalent live-attenuated viral vaccine against bovine respiratory infections in combination with treatment with an anti-PD-L1 Ab. The expression kinetics of PD-1 in T cells and T-cell responses to viral antigens were measured before and after vaccination to evaluate the adjuvant effect of anti-PD-L1 Ab. PD-1 expression was upregulated in vaccinated calves after the administration of a booster vaccination. The activation status of CD4 + , CD8 + , and γδTCR + T cells was enhanced by the combination of vaccination and PD-L1 blockade. In addition, IFN-γ responses to viral antigens were increased following combinatorial vaccination with PD-L1 blockade. In conclusion, the blockade of the PD-1/PD-L1 interaction enhances T-cell responses induced by vaccination in cattle, indicating the potential utility of anti-PD-L1 Ab in improving the efficacy of current vaccination programs.
Keyphrases
  • sars cov
  • dendritic cells
  • poor prognosis
  • early stage
  • immune response
  • regulatory t cells
  • endothelial cells
  • cancer therapy
  • human health
  • long non coding rna
  • combination therapy
  • stress induced